BETANOL (TABLETS)

Presentation

BETANOL Tablets: Light yellow, coated tablet; each tablets; contains 50 mg atenolol BP.

BETANOL 100 mg Tablets:  Light yellow, coated, circular tablets: each tablets contains 100 mg atenolol BP.

 Uses

1.       Management of hypertension.

2.       Management of angina pectoris.

3.       Management of cardiac dysrhythmias.

4.       Myocardial infarction: early intervention in the acute phase.

Mode of Action

Atenolol is a beta-adrenoceptor blocking drug which is cardioselective (i.e..,acts preferentially on beta adrenergic receptors in the heart). It is without intrinsic sympathomimetic and membrance stabilising activities. Human studies indicate that it crosses the blood brain barrier only to a negligible extent. It is probably the action of atenolol in reducing cardiac rate and contractility which makes it effective in eliminating or reducing the symptoms of patients with angina. As with other beta-adrenoceptor blocking drugs, its mode of action in the treatment of hypertension is unclear.

Early intervention with atenolol in acute myocardial infarction reduces infarct size and decreases morbidity. Fewer patientswith a threatened infarction progress to frank infarction; the incidence of ventricular arrhythmias is decreased and marked pain relief may result in reduced need of opiate analgesics. Early mortality also may be decreased. Atenolol is an additional treatment to standard coronary care.

Dosage and administration

Adults:

Hypertension: One tablet daily. most patient respond to 100 mg daily given as a single dose. Some patients, however, will respond to 50mg given as a single daily dose. The effect will be fully estabilished after one to two weeks. A further reduction in bloood pressure may be acheved by combining BETANOL wiht other anti-hypertensive agents. Foe example, co-administartion of BETANOL with a diuretic provides a hyghly effective and convenient anti-hypertensive therapy.

Angina: Most patient with angina pectoris will responed to 100 mg given orally once daily or 50 mg twie daily. it is unlikely that additional benefit will be gained by increasing the dose.

Dysrhythmias: Once control of the dysrhythmias is achieved by intravenous injection of beta-adrenoceptor blocking drugs, BETANOL tablets may be given. A suitable oral, maintenance dosage is 50-100 mg daily given as a single dose.

Myocardial Infarction:   For patients suitable for treatment with intravenous beta-blockage and presenting within 12 hours of the onest of chest pain. Following slow intravenous injection of a cardio selective beta-adrenoceptor blocking drug, BETANOL 50 mg orally may be given 15 minutes later provided no untoward effects occur from the  intravenous dose.

This should be followed by a further 50mg orally 12 hours after the intravenous dose and then 12 hours later by 100 mg orally to be given once daily for up to 10 days . If bradycardia and/or hypotension requiring treatment, or any other untoward effects occur, BETANOL should be discontinued.

Eldrely Patients : Dosage requirements may be reduced especially in patients with impaired renal function.

Children:

There is no pediatric experience with BEANOL and for this reason it is not recommended for use in children.     

FIRIFAM- CAPSULES

Presentation

FIRIFAN 150 Capsules: Brown capsules imprinted ‘FIRIFAM 150 mg; each capsule contains 150mg rifampicin BP.

FIRIFAM 450 Capsules: Maroon capsules imprinted with company logo and FIRIFAM 450mg;  each capsuls contains 450mg fifampicin BP.

Uses

FIRIFAM used in combination with other antituberculous drugs, is indicated in the treatment of all form of tuberculosis, including fresh, advanced, chronic and drug resistant cases. it has been used in the treatment of tuberculous meningitis and in combination with other antileprotics. It is also used in the treatment of leprosy.

Dosage and administration

To prevent the possible emergence of rifampicin- resistat strains of mycobacteria. FIRIFAM shoud always be given with other effective antituberculous drugs. The single dose should preferably be taken on an empty stomach at least helf an hour before food.

Adults: Oral: Based on approximately 8 to 12 mg per kg body weight, the recommended dose of fifampicin is 600 mg daily for patients weighing 50kg and above and 450mg for patients under 50 kg in patients with impaired live function the daily dose should not exceed 8mg per kg body weight.

Children: Children may be given 10 to 20 mg per kg body weight to maximum daily dose of 600 mg.

PEVISONE- CREAM

Presentation

PEVISONE Cream: A white cream containing 1% econazole nitrate BP and 0.1% triamcinolone acetonide BP.

Uses

Econazole nitrate is a broad spectrum antifungal agent. Its range of application covers dermatophytes, yeasts and moulds.Moreover, it has antibacterial effect on Gram-positive pathogens. Triamcinolone acetonide is a highly effective topical steroid with rapid anti-inflammatory, antipruritic and anti-allergic action. At the concentration chosen for anti-allergic action. At the concentration chosen for PEVISONE. the two active substances econazole nitrate and triamcinolone acetonide develop their ful activity.

The major indications of PEVISONE are dermatomycoses caused by dermatophytes, yeasts and fungi, accompanied by distinct inflammatory or allergic symptoms, e.g.. eczematous mycoses; diaper dermatitis; eczema marginaturn;intertrigo; folliculitis trichophytica; sycosis barbae.

PEVISONE is also indicated for the treatment of mycoses located in the region of body folds where inflammation or intolerance of drugs or adjutants may develop.

Dosage and administration

PEVISONE is applied to the affected are and gently rubbed in with the finger; this should be done once or twice a day; in the morning and/or n the evening. A two-week therapy with PEVISONE is usaually sufficient to control the concomitant inflammatory symptoms of mycoses.Thereafter, treatment with PEVARYL should be started and continued until complete cure is obtained Occlusive dressings should not be used. Like with any other steroidal perparation the duration treatmetn should be limited to a period of 3-4 weeks, as otherwise the skin may be damaged by the steroid effect (atrophy, telangicetases, striae)

FIDAPLEX- INJECTION

Presentation

FIDAPLED Injection: Clear yellow solution each 2 ml amber ampoule contains 100 mg thiamine hydrocholoride BP. 100 mg pyridoxine hydrocholoride BP and 6.4mg riboflavine sodium phosphate BP.

Uses

FIDAPLEX, a combination of thiamine, riboflavine and pyrioxine is used for the prevention and treatment of these vitamin deficiencies including those arising from debility after illness, operation, renal dialysis pregneancy, hyperthyroidism, prolonged antibiotic theraph and old age associated with poor diet.

It is indicated in the treatment of beri-beri and also improves fatigue anorexia, gastro-intestinal disturbances, tachycardia, irritability and neurological symptoms due to thiamine deficiency. The presence of riboflavine produces improvement of angular stomatitis. golssitis, reddened, shiny and denuded lips, seborrhoeic follicular keratosis of the nasolabial folds. nose and forehead, dermatitis of the anogenital regions and burning feet, when these are due to a deficiency of the vitamin. in the body, pyridoxine hydrochloride not only acts as a co-enzyme for a variety of metabolic transformations but also alleviates megaloblastic anaemia and peripheral neuritis associated with its deficiency.

Dosage and administration

Audlt: Intramuscular or intravenous injections of 2 ml every day or alternative days.

METRONID- TABLET

Presentation

METRONID 200-Tablets: Light yellow, coated circular tablets: each tablet contains 200gm metronidazol BP.

METRONID 400-Tablets: Light yellow, coated circular tablets: each tablet contains 400gm metronidazol BP.

METRONID Suspension: Yellow coloured, orange flavored suspension; each 5ml contains benzoylmetronidazole equivalent to 200mg metronidazole BP.

Uses

METRONID, an antiprotozoal and antibacterial agent, is active against Trichomonas virginals, Endameba histolytica, Guardia lamblia, Gardnerella virginals, Balantidium coli. Dracunculus medinensis, it is also effective against anaerobic bacteria and is used in the prophylaxis and treatment of infections caused by anaerobic organisms particularly species of Bacteroides, Fusobacteria. Eubacteria, Colostridia and anaerobic cocci (peptococci and Peptostreptococci).

It is indicated in:

-         Trichomoniasis of the genito-urinary tract in females( trichomonal vaginitis) and males.

-         Bacterial vaginosis(non-specific vaginitis)

-         All forms of amoebiasis (intestinal and extra-intestinal disease and that of symptomless cyst passers)

-         Giardiasis

-         Acute ulcerative gingivitis

-         An aerobically-infected leg ulcers and pressure sores

-         Acute dental infections (e.g.. acute pericoronitis and acute apical infections)

-         Infections due to susceptible anaerobic organisms.

-         Prevention of post-operative infections due to anaerobic organisms.

-         Blantidiasis

-         Dracunculiasis

-         Antibibiotic-associated colitis.

Dosage and administration

METRONID tablets should preferably be taken during or after a meal and the suspension at least one hour before a meal. Tablets should be swallowed without chewing

Oral medication corresponding to the indication is shown in the tablet( all dosage are given in terms of metronidazole or metronidazole equivalent) after the ‘package quantities;

FITAMOL- TABLET

Presentation

FITAMOL-Tablets: White, scored, circular tablets, engraved with ‘FITAMOL; each tablet contains 500gm paracetamol BP.

FITAMOL-Suspension: Red coloured, orange flavoured suspension; each 5 ml contains 120 mg paracetamol BP.

Uses

FITAMOL is a a mild analgesic and antipyretic. The tablets are recommended for the symptomatic treatment for the majority of painful and febrile conditions, for example, headache, toothache, neuralgia, influenza, rheumatic pain, and dysmenorrhoea.

FITAMOL suspension is recommended for the symptomatic treatment of painful and febrile conditions of childhood such as teething, headache, toothache, earache, general aches and pains, and influenza.

Dosage and administration

For oral administration only:

FITAMOL tablet:

Adults: The usual dosage is 1 to 2 tablets every 3 or 4 hours with a maximum of 8 tablets in 24 hours.

Children: Children should not be given doses of FITAMOL more frequently than every 4 hours and not more than 4 doses should be given in any 24 hours.

6 to 12 years: 1 tablet 3 or 4 times daily as required.

FITAMOL-Suspension:

Children:  3 months to 1 year : 5 ml.

(1 teaspoonful) 3 or 4 times daily as required.

1 to 5 years : 5 to 10 ml(1 to 2 teaspoonfuls) 3 or 4 times daily as required.

6 to 12 years: 10 to 20 ml(2 to 4 teaspoonfuls) 3 or 4 times daily as required.

GLUCOTAB- TABLET

Presentation

GLUCOTAB-Tablets: White, scored, oblong tablets, engraved with ‘GLUCOTAB; each tablet contains 5gm glibenclamide BP.

Uses

GLUCOTAB is an oral hypoglycaemic agent of the sulphonylurea type. GLUCOTAB is indicated for the treatment of non-insulin dependent diabetes which is not adequately controlled by dietary measures alone.

Dosage and administration

GLUCOTAB should be taken with or immediately after food. The total daily dosage is preferably given as a single dose at breakfast or with the first main meal. but due consideration should be given to the patient’s meal habits and daily activity when apportioning dosage.

New diabetics: In maturity-onset diabetes of mild to moderate severity, treatment should be started with 5 mg daily of 2.5mg in debilitated or elderly patients. If this dosage is not sufficient for proper control it should be increased by 2.5mg at intervals of one week, or as directed by the clinician. The total daily dose of GLUCOTAB should not exceed 15mg. Increasing dosage beyond this level is unlikely to produce further response.

Transfer from other sulphonylureas: Transfer to GLUCOTAB can e usually by carried out without any break in therapy. GLUCOTAB treatment should be started with 5 mg daily and , if necessary, adjusted in steps of 2.5 or 5 mg. dosage is 1 to 2 tablets every 3 or 4 hours with a maximum of 8 tablets in 24 hours.

Changeover from biguanides: GLUCOTAB treatment should be started with 2.5 mg of GLUCOTAB and the biguanide withdrawn. Dosage should then be adjusted by increments of 2.5 mg to achieve control.